Skip to main content
Top
Published in: Cancer Causes & Control 9/2012

Open Access 01-09-2012 | Original paper

Most colorectal cancer survivors live a large proportion of their remaining life in good health

Authors: Isabelle Soerjomataram, Melissa S. Y. Thong, Majid Ezzati, Elizabeth B. Lamont, Wilma J. Nusselder, Lonneke V. van de Poll-Franse

Published in: Cancer Causes & Control | Issue 9/2012

Login to get access

Abstract

Purpose

Colorectal cancer (CRC) diagnosis reduces life expectancy and decreases patients’ well-being. We sought to assess the determinants of health and functional status and estimate the proportion of remaining life that CRC survivors would spend in good health.

Methods

Using Sullivan method, healthy life expectancy was calculated based on survival data of 14,849 CRC survivors within a population-based cancer registry in southern Netherlands and quality of life information among a random sample of these survivors (n = 1,291).

Results

Overall, albeit short life expectancy (LE at age 50 = 12 years for males and 13 years for females), most CRC survivors spent a large proportion of their remaining life in good health (74 and 77 %, for males and females, respectively). Long-term survivors may expect to live a normal life span (LE at age 50 = 30 years) and spent a large proportion of the remaining life in good health (78 %). In distinction, those with stage IV CRC had less than 2 years to live and spent more than half of their remaining life in poor health.

Conclusions

Most CRC patients may expect no compromise on living a healthy life, underlining the importance of early detection. On the other hand, the high proportion of non-healthy years among stage IV CRC survivors confirms the importance of early detection and palliative care.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gondos A, Bray F, Hakulinen T, Brenner H (2009) Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol 20:564–573PubMedCrossRef Gondos A, Bray F, Hakulinen T, Brenner H (2009) Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol 20:564–573PubMedCrossRef
2.
go back to reference Ramsey SD, Andersen MR, Etzioni R et al (2000) Quality of life in survivors of colorectal carcinoma. Cancer 88:1294–1303PubMedCrossRef Ramsey SD, Andersen MR, Etzioni R et al (2000) Quality of life in survivors of colorectal carcinoma. Cancer 88:1294–1303PubMedCrossRef
3.
go back to reference Gatta G, Ciccolallo L, Faivre J, Bouvier AM, Berrino F, Gerard JP (2007) Late outcomes of colorectal cancer treatment: a FECS-EUROCARE study. J Cancer Surviv 1:247–254PubMedCrossRef Gatta G, Ciccolallo L, Faivre J, Bouvier AM, Berrino F, Gerard JP (2007) Late outcomes of colorectal cancer treatment: a FECS-EUROCARE study. J Cancer Surviv 1:247–254PubMedCrossRef
4.
go back to reference Schneider EC, Malin JL, Kahn KL, Ko CY, Adams J, Epstein AM (2007) Surviving colorectal cancer: patient-reported symptoms 4 years after diagnosis. Cancer 110:2075–2082PubMedCrossRef Schneider EC, Malin JL, Kahn KL, Ko CY, Adams J, Epstein AM (2007) Surviving colorectal cancer: patient-reported symptoms 4 years after diagnosis. Cancer 110:2075–2082PubMedCrossRef
5.
go back to reference Shahir MA, Lemmens VE, van de Poll-Franse LV, Voogd AC, Martijn H, Janssen-Heijnen ML (2006) Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study. Eur J Cancer 42:3015–3021PubMedCrossRef Shahir MA, Lemmens VE, van de Poll-Franse LV, Voogd AC, Martijn H, Janssen-Heijnen ML (2006) Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study. Eur J Cancer 42:3015–3021PubMedCrossRef
6.
go back to reference Dunn J, Lynch B, Aitken J, Leggett B, Pakenham K, Newman B (2003) Quality of life and colorectal cancer: a review. Aust N Z J Public Health 27:41–53PubMedCrossRef Dunn J, Lynch B, Aitken J, Leggett B, Pakenham K, Newman B (2003) Quality of life and colorectal cancer: a review. Aust N Z J Public Health 27:41–53PubMedCrossRef
7.
go back to reference Janssen-Heijnen ML, Louwman WJ, van de Poll-Franse LV, Coebergh JWW (2005) Results of 50 years cancer registry in the South of the Netherlands: 1955–2004. Eindhoven Cancer Registry, Eindhoven Janssen-Heijnen ML, Louwman WJ, van de Poll-Franse LV, Coebergh JWW (2005) Results of 50 years cancer registry in the South of the Netherlands: 1955–2004. Eindhoven Cancer Registry, Eindhoven
8.
go back to reference Wittekind C, Greene FL, Hutter RVP, Klimpfinger M, Sobin LH (2005) TNM Atlas, 5th edn. Springer, HeidelbergCrossRef Wittekind C, Greene FL, Hutter RVP, Klimpfinger M, Sobin LH (2005) TNM Atlas, 5th edn. Springer, HeidelbergCrossRef
9.
go back to reference van Duijn C, Keij I (2002) Sociaal-economische status indicator op postcode niveau. Maandstatistiek van de bevolking 50:32–35 van Duijn C, Keij I (2002) Sociaal-economische status indicator op postcode niveau. Maandstatistiek van de bevolking 50:32–35
10.
go back to reference Aaronson NK, Muller M, Cohen PD et al (1998) Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 51:1055–1068PubMedCrossRef Aaronson NK, Muller M, Cohen PD et al (1998) Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 51:1055–1068PubMedCrossRef
11.
go back to reference Thong MS, Mols F, Lemmens VE, Creemers GJ, Slooter GD, van de Poll-Franse LV (2011) Impact of chemotherapy on health status and symptom burden of colon cancer survivors: a population-based study. Eur J Cancer 47:1798–1807PubMedCrossRef Thong MS, Mols F, Lemmens VE, Creemers GJ, Slooter GD, van de Poll-Franse LV (2011) Impact of chemotherapy on health status and symptom burden of colon cancer survivors: a population-based study. Eur J Cancer 47:1798–1807PubMedCrossRef
12.
go back to reference Thong MS, Mols F, Lemmens VE et al (2011) Impact of preoperative radiotherapy on general and disease-specific health status of rectal cancer survivors: a population-based study. Int J Radiat Oncol Biol Phys 81:e49–e58PubMedCrossRef Thong MS, Mols F, Lemmens VE et al (2011) Impact of preoperative radiotherapy on general and disease-specific health status of rectal cancer survivors: a population-based study. Int J Radiat Oncol Biol Phys 81:e49–e58PubMedCrossRef
13.
go back to reference National Working Group on Gastrointestinal Cancers (2008) Oncoline: cancer clinical practice guidelines. VIKC, Utrecht National Working Group on Gastrointestinal Cancers (2008) Oncoline: cancer clinical practice guidelines. VIKC, Utrecht
14.
15.
go back to reference Jagger C, Cox B, Le Roy S (2006) EHEMU: health expectancy calculation by the Sullivan method: a practical guide Jagger C, Cox B, Le Roy S (2006) EHEMU: health expectancy calculation by the Sullivan method: a practical guide
17.
go back to reference Janssen-Heijnen ML, Gondos A, Bray F et al (2010) Clinical relevance of conditional survival of cancer patients in Europe: age-specific analyses of 13 cancers. J Clin Oncol 28:2520–2528PubMedCrossRef Janssen-Heijnen ML, Gondos A, Bray F et al (2010) Clinical relevance of conditional survival of cancer patients in Europe: age-specific analyses of 13 cancers. J Clin Oncol 28:2520–2528PubMedCrossRef
18.
go back to reference Bruggink JW, Lodder B, Kardal M (2009) Healthy life expectancy higher. Statistics Netherlands, Den Haag Bruggink JW, Lodder B, Kardal M (2009) Healthy life expectancy higher. Statistics Netherlands, Den Haag
19.
go back to reference Moinpour CM, Sawyers Triplett J, McKnight B et al (2000) Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial. Psycho-oncology 9:340–354PubMedCrossRef Moinpour CM, Sawyers Triplett J, McKnight B et al (2000) Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial. Psycho-oncology 9:340–354PubMedCrossRef
20.
go back to reference Dunn J, Lynch B, Rinaldis M et al (2006) Dimensions of quality of life and psychosocial variables most salient to colorectal cancer patients. Psycho-oncology 15:20–30PubMedCrossRef Dunn J, Lynch B, Rinaldis M et al (2006) Dimensions of quality of life and psychosocial variables most salient to colorectal cancer patients. Psycho-oncology 15:20–30PubMedCrossRef
21.
go back to reference Ramfelt E, Severinsson E, Lutzen K (2002) Attempting to find meaning in illness to achieve emotional coherence: the experiences of patients with colorectal cancer. Cancer Nurs 25:141–149PubMedCrossRef Ramfelt E, Severinsson E, Lutzen K (2002) Attempting to find meaning in illness to achieve emotional coherence: the experiences of patients with colorectal cancer. Cancer Nurs 25:141–149PubMedCrossRef
22.
go back to reference Anthony T, Jones C, Antoine J, Sivess-Franks S, Turnage R (2001) The effect of treatment for colorectal cancer on long-term health-related quality of life. Ann Surg Oncol 8:44–49PubMedCrossRef Anthony T, Jones C, Antoine J, Sivess-Franks S, Turnage R (2001) The effect of treatment for colorectal cancer on long-term health-related quality of life. Ann Surg Oncol 8:44–49PubMedCrossRef
23.
go back to reference Marijnen CA, van de Velde CJ, Putter H et al (2005) Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 23:1847–1858PubMedCrossRef Marijnen CA, van de Velde CJ, Putter H et al (2005) Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 23:1847–1858PubMedCrossRef
24.
go back to reference Trentham-Dietz A, Remington PL, Moinpour CM, Hampton JM, Sapp AL, Newcomb PA (2003) Health-related quality of life in female long-term colorectal cancer survivors. Oncologist 8:342–349PubMedCrossRef Trentham-Dietz A, Remington PL, Moinpour CM, Hampton JM, Sapp AL, Newcomb PA (2003) Health-related quality of life in female long-term colorectal cancer survivors. Oncologist 8:342–349PubMedCrossRef
25.
26.
go back to reference Salomon JA, Tandon A, Murray CJ (2004) Comparability of self rated health: cross sectional multi-country survey using anchoring vignettes. BMJ (clinical research edition) 328:258CrossRef Salomon JA, Tandon A, Murray CJ (2004) Comparability of self rated health: cross sectional multi-country survey using anchoring vignettes. BMJ (clinical research edition) 328:258CrossRef
27.
go back to reference Oort FJ (2005) Using structural equation modeling to detect response shifts and true change. Qual Life Res 14:587–598PubMedCrossRef Oort FJ (2005) Using structural equation modeling to detect response shifts and true change. Qual Life Res 14:587–598PubMedCrossRef
28.
go back to reference Jansen L, Herrmann A, Stegmaier C, Singer S, Brenner H, Arndt V (2011) Health-related quality of life during the 10 years after diagnosis of colorectal cancer: a population-based study. J Clin Oncol 29:3263–3269PubMedCrossRef Jansen L, Herrmann A, Stegmaier C, Singer S, Brenner H, Arndt V (2011) Health-related quality of life during the 10 years after diagnosis of colorectal cancer: a population-based study. J Clin Oncol 29:3263–3269PubMedCrossRef
Metadata
Title
Most colorectal cancer survivors live a large proportion of their remaining life in good health
Authors
Isabelle Soerjomataram
Melissa S. Y. Thong
Majid Ezzati
Elizabeth B. Lamont
Wilma J. Nusselder
Lonneke V. van de Poll-Franse
Publication date
01-09-2012
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 9/2012
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-0010-2

Other articles of this Issue 9/2012

Cancer Causes & Control 9/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine